Oestrogen receptors and linear bone growth

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 9, 2007, Pages 1275-1279

  Chagin, Andrei S ^a,b   Sävendahl, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Growth plate; Longitudinal bone growth; Oestrogen receptors; Selective oestrogen receptor modulators

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

BONE GROWTH; BREAST CANCER; ESTROGEN ACTIVITY; GROWTH PLATE; GYNECOMASTIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTHROPOMETRY; AROMATASE INHIBITORS; BONE DEVELOPMENT; CHILD; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FEMUR; GROWTH DISORDERS; HUMANS; MALE; MICE; MICE, KNOCKOUT; NITRILES; PHENOTYPE; PUBERTY; TESTOSTERONE; TRIAZOLES;

EID: 34548140537     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00415.x     Document Type: Review

References (51)

1. Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med 1986 315 : 1115 9.
2. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994 331 : 1056 61.
3. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995 80 : 3689 98.
4. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998 339 : 599 603.
5. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997 337 : 91 5.
6. Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004 89 : 61 70.
7. Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet 2001 357 : 1743 8.
8. Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 2005 90 : 6396 402.
9. Hero M, Wickman S, Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol (Oxford) 2006 64 : 510 3.
10. Kaplan SL, Grumbach MM. Clinical review 14: pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 1990 71 : 785 9.
11. Conte FA, Grumbach MM. Estrogen use in children and adolescents: a survey. Pediatrics 1978 62 : 1091 7.
12. Barnard ND, Scialli AR, Bobela S. The current use of estrogens for growth-suppressant therapy in adolescent girls. J Pediatr Adolesc Gynecol 2002 15 : 23 6.
13. Goldzieher MA. Treatment of excessive growth in the adolescent female. J Clin Endocrinol Metab 1956 16 : 249 52.
14. Rookus MA, van Leeuwen FE. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Lancet 1994 344 : 844 51.
15. Venn A, Bruinsma F, Werther G, Pyett P, Baird D, Jones P, et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet 2004 364 : 1513 8.
16. McDonnell DP. The molecular pharmacology of SERMs. Trends Endocrinol Metab 1999 10 : 301 11.
17. Barrett-Connor E. Raloxifene: risks and benefits. Ann N Y Acad Sci 2001 949 : 295 303.
18. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003 348 : 618 29.
19. Lewis JS, Jordan VC. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat Res 2005 591 : 247 63.
20. Kreher NC, Eugster EA, Shankar RR. The use of tamoxifen to improve height potential in short pubertal boys. Pediatrics 2005 116 : 1513 5.
21. Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003 143 : 60 6.
22. Eugster EA, Shankar R, Feezle LK, Pescovitz OH. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome. J Pediatr Endocrinol Metab 1999 12 : 681 6.
23. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004 145 : 71 6.
24. Li X, Takahashi M, Kushida K, Koyama S, Hoshino H, Kawana K, et al. The effect of tamoxifen on bone metabolism and skeletal growth is different in ovariectomized and intact rats. Calcif Tissue Int 1996 59 : 271 6.
25. Chagin AS, Karimian E, Zaman F, Takigawa M, Chrysis D, Savendahl L. Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones. Bone 2007 40 : 1415 24.
26. Fitts JM, Klein RM, Powers CA. Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis. J Androl 2004 25 : 523 34.
27. Nilsson O, Falk J, Ritzen EM, Baron J, Savendahl L. Raloxifene acts as an estrogen agonist on the rabbit growth plate. Endocrinology 2003 144 : 1481 5.
28. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993 90 : 11162 6.
29. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998 95 : 15677 82.
30. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000 127 : 4277 91.
31. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 2000 97 : 5474 9.
32. Vidal O, Lindberg M, Savendahl L, Lubahn DB, Ritzen EM, Gustafsson JA, et al. Disproportional body growth in female estrogen receptor-alpha-inactivated mice. Biochem Biophys Res Commun 1999 265 : 569 71.
33. Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002 30 : 18 25.
34. Chagin AS, Lindberg MK, Andersson N, Moverare S, Gustafsson JA, Savendahl L, et al. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J Bone Miner Res 2004 19 : 72 7.
35. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999 104 : 895 901.
36. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G. Female estrogen receptor beta -/- mice are partially protected against age-related trabecular bone loss. J Bone Miner Res 2001 16 : 1388 98.
37. Lindberg MK, Alatalo SL, Halleen JM, Mohan S, Gustafsson JA, Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol 2001 171 : 229 36.
38. Tozum TF, Oppenlander ME, Koh-Paige AJ, Robins DM, McCauley LK. Effects of sex steroid receptor specificity in the regulation of skeletal metabolism. Calcif Tissue Int 2004 75 : 60 70.
39. Parikka V, Peng Z, Hentunen T, Risteli J, Elo T, Vaananen HK, et al. Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur J Endocrinol 2005 152 : 301 14.
40. Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999 140 : 5566 78.
41. Pettersson K, Delaunay F, Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000 19 : 4970 8.
42. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, et al. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 2002 99 : 2205 10.
43. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 2000 19 : 4688 700.
44. Chagin A, Nilsson M, Dahlman Wright K, Savendahl L. Remaining estrogenic activity in the man with mutated estrogen receptor alpha (ERα). Horm Res 2006 65 Suppl 4 : 28.
45. Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, et al. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 2000 27 : 611 7.
46. Nelson JF, Felicio LS, Osterburg HH, Finch CE. Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology 1992 130 : 805 10.
47. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 1975 96 : 219 26.
48. Pediatric endocrine testing: reference ranges. San Juan Capistrano, Puerto Rico : Nichols Institute, 1993.
49. Albertsson-Wikland K, Rosberg S, Lannering B, Dunkel L, Selstam G, Norjavaara E. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab 1997 82 : 541 49.
50. Norjavaara E, Ankarberg C, Albertsson-Wikland K. Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay. J Clin Endocrinol Metab 1996 81 : 4095 102.
51. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001 276 : 36869 72.